|
Benchmark Studies
The benchmark studies below are part of Best Practices, LLC's ongoing Research and Consulting initiatives. By participating in one of the following surveys, you will receive a free copy of the results in presentation format. All benchmark study results are blinded and aggregated to ensure confidentiality.
You can access free excerpts of previous studies archived under Benchmarking Reports and Best Practice Database.
Developing World-Class Regulatory Systems That Lead to Successful NDAs and Optimize FDA Working Relationships
Survey Topic: Developing World-Class Regulatory Systems That Lead to Successful NDAs and Optimize FDA Working Relationships
Objective: Bringing New Drug Applications (NDA) through the Food and Drug Administration (FDA) approval process is the gateway to commercial success. However, increasing safety concerns, market and political pressures, make this NDA approval process more difficult than ever.
Those companies that develop effective systems to work with the FDA enjoy a critical advantage in the commercialization process.
This biopharmaceutical benchmarking study is designed to gain insights into how pharmaceutical companies successfully interact with employees of the Food and Drug Administration during the NDA process.
Lead Researcher: Cameron Tew
Invited Participants: Executives that oversee, manage and direct functions that interact with the Food and Drug Administration during the New Drug Application process.
 Contact: To participate in this survey, please contact Cameron Tew at (919)-767-9246 or ctew@best-in-class.com.
Thought Leader Fair Market Value - 2016
Survey Topic: Thought Leader Fair Market Value - 2016
Objective: With increasing importance of transparency, healthcare leaders must provide a clear line of sight into how they compensate industry thought leaders and physicians. Bio-pharma executives are being pressed to re-assess their current thought leader compensation strategies as new state reporting laws and changes to their organizations’ policies (PhRMA code, ACCME guidelines, etc.) are being enforced. At the same time, access to thought leaders themselves has continued to shrink, whether in academic institutions or elsewhere.
Put simply, it has never been more important for healthcare companies to get it right when it comes to thought leader management. This benchmarking study is designed to examine trends in Fair Market Value for thought leaders, capturing critical metrics and insights on thought leader management, compensation levels, and proven practices.
Lead Researcher: Cameron Tew
Invited Participants: Vice presidents, executives, directors, managers, and other professionals working within Medical Affairs and thought leader management functions.
Time Commitment: Approximately  25-30 minutes
Contact: To participate in this survey, please contact Cameron Tew at (919)-767-9246 or ctew@best-in-class.com.
Winning the Necessary Resources for a Successful Product Launch
Survey Topic: Winning the Necessary Resources for a Successful Product Launch
Objective: Pharmaceutical companies can no longer afford to rely solely on past experience when budgeting for a new product launch in today's fast-changing, highly competitive market. This comprehensive benchmark study investigates current costs as well as budget and staffing allocations required for a successful drug launch.Pharmaceutical leaders who participate in this study can use the resulting benchmark data to determine whether their own investment levels for promotional, educational, market access, Medical Affairs, and other launch-related activities are competitive in the new marketplace.
Lead Researcher: Cameron Tew
Invited Participants: Pharma and biotech executives, directors, managers, and brand team leaders who have recent or current experience with the launch (or launch preparation) of a new pharmaceutical product.
Contact: To participate in this survey, please contact Cameron Tew, Head of Research, at (919)-767-9246 or ctew@best-in-class.com.
|
-----------------------------------------
Scott Brown, Ph.D,
Executive Director of Global Research Operations and Consulting Services
Phone: (919) 767-9164
 Email Scott Brown
|